Florida’s HedgePath Pharmaceuticals heralded a positive midstage study for its oral capsules designed to treat a complication associated with basal cell…

Researchers have uncovered a new gene therapy that can replace a deficient enzyme in patients suffering from the neurodegenerative disorders Tay-Sachs and…

Sunovion’s COPD treatment passed muster in Phase III for both safety and efficacy, marking a success for its quick-acting nebulizer delivery system.

Rare-disease specialist Soligenix has picked up two new funding rounds totaling more than $600,000 to support its preclinical work on a military and civilian…

Researchers at Texas A&M University have developed a nano-sized delivery system that could help bring injected treatments such as insulin into the oral…

The New Jersey Institute of Technology received a $1 million grant from the W. M. Keck Foundation it will use to study new materials for nanotechnology.

Researchers at Texas A&M are developing an inhaled version of ibuprofen using nanoparticles.

A study published in the American Society for Microbiology’s journal has shown that a new “stealth” nanoparticle cured more than half of mice infected by the…